Navigation Links
PuraMed BioScience Sponsors Miles for Migraine Race with LipiGesic M
Date:8/22/2013

SCHOFIELD, Wis., Aug. 22, 2013 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCBB:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that it will sponsor the 5th Miles for Migraine Race San Francisco by supplying $5,000 of LipiGesic M for the participants.

Miles for Migraine, a registered 501c3 nonprofit, will host the 5th Miles for Migraine race on September 14, 2013 in San Francisco. "We are honored to be part of the effort to increase the awareness of migraine," said Russ Mitchell, CEO PuraMed BioScience. "Miles for Migraine and PuraMed BioScience share the same goal: to improve the lives of people who suffer with migraine. It's a great fit.

"We hope that we will not only help increase awareness, but also hope that by donating LipiGesic M that we will give the runners a tool for migraine treatment that stops migraine pain," said Mitchell.

LipiGesic M is a homeopathic formulation of feverfew and ginger delivered in a sublingual gel. Clinical trial results show that LipiGesic M has an efficacy rate that exceeds the number-one-selling triptan medication. In addition, LipiGesic M has not been shown, in the clinical trial or in everyday use, to cause drowsiness or rebound headache even if a migraineur takes the medication frequently.

"More people suffer from migraine than diabetes and asthma combined; yet it receives a fraction of funding for research," said Miles for Migraine Executive Director Joanne Fedeyko. "With local and national growth key to our mission of raising awareness, I'm thrilled San Francisco will once again host Miles for Migraine and help spread the word that migraine is more than 'just a headache.' With one in four American families impacted by migraine, we know that there is a huge population to get behind our cause."

Migraine is the leading brain disorder in the United States. Over 50 million American adults, teens, and children suffer from migraines or sinus headaches, which are often misdiagnosed migraines. In a 2004 report, the World Health Organization (WHO) classified severe migraine in the same category of disability with quadriplegia or terminal stage cancer.

General Event Information for 2013
The 5th Miles for Migraine San Francisco race takes place on Saturday September 14th at 8 a.m. in Golden Gate Park, in San Francisco, California. Fees range from $31 for the 2-Mile Walk to $41 for the 10K. Register online at www.milesformigraine.org

Forward-Looking Statements:
This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different than those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Contact:
PuraMed BioScience, Inc.
Patricia McMurtrie, VP Marketing
715-571-4910
patricia@PuramedBioScience.com
www.PuramedBioScience.com


'/>"/>
SOURCE PuraMed BioScience, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PuraMed BioScience Discusses Potential for Patent Portfolio Acquisition
2. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
4. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
5. Neurocrine Biosciences Reports First Quarter 2012 Results
6. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
7. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
8. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
9. HUYA Bioscience International Engages In Partnership With Zhuhai Sanzao Science and Technology Industrial Park
10. Tethys Bioscience and Lose it! Announce a Strategic Partnership to Support Diabetes Prevention
11. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... Ill. , June 23, 2016  In a startling report ... are failing their residents by lacking a comprehensive, proven plan to ... a definitive ranking of how states are tackling the worst ... to only four states – Kentucky , ... Vermont . Of the 28 failing states, three ...
Breaking Medicine Technology:
(Date:6/26/2016)... N.J. (PRWEB) , ... June 27, 2016 , ... Quality ... sources, yet in many ways they remain in the eye of the beholder, according ... (EBO), a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
Breaking Medicine News(10 mins):